Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2025 |
43,882 |
137,913
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2025 |
8,400 |
26,400
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.02 per share. |
09 Jun 2025 |
8,400 |
135,903
|
-
|
10.0 |
84,168
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
09 Jun 2025 |
94,027 |
94,027
|
-
|
4.3 |
404,316
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.03 per share. |
09 Jun 2025 |
43,882 |
0
|
-
|
10.0 |
440,136
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
09 Jun 2025 |
8,400 |
144,303
|
-
|
4.3 |
36,120
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
09 Jun 2025 |
18,000 |
153,903
|
-
|
4.3 |
77,400
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.02 per share. |
09 Jun 2025 |
43,883 |
0
|
-
|
10.0 |
439,708
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
09 Jun 2025 |
43,883 |
43,883
|
-
|
4.3 |
188,697
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2025 |
94,027 |
3
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2025 |
18,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2025 |
43,883 |
94,030
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Jun 2025 |
8,400 |
18,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
09 Jun 2025 |
8,400 |
144,303
|
-
|
4.3 |
36,120
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.03 per share. |
09 Jun 2025 |
8,400 |
135,903
|
-
|
10.0 |
84,252
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
09 Jun 2025 |
43,882 |
43,882
|
-
|
4.3 |
188,693
|
Common Stock |
David L. Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
38,227 |
38,227
|
-
|
4.3 |
164,376
|
Common Stock |
David L. Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
38,228 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
David L. Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
38,227 |
38,228
|
-
|
|
-
|
Stock Option (Right to Buy) |
David L. Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
38,227 |
76,455
|
-
|
|
-
|
Stock Option (Right to Buy) |
David L. Hallal
|
Director |
Sale of securities on an exchange or to another person at price $ 10.24 per share. |
04 Jun 2025 |
38,228 |
0
|
-
|
10.2 |
391,455
|
Common Stock |
David L. Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
38,228 |
38,228
|
-
|
4.3 |
164,380
|
Common Stock |
David L. Hallal
|
Director |
Sale of securities on an exchange or to another person at price $ 10.15 per share. |
04 Jun 2025 |
38,227 |
0
|
-
|
10.1 |
388,004
|
Common Stock |
David L. Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
38,227 |
38,227
|
-
|
4.3 |
164,376
|
Common Stock |
David L. Hallal
|
Director |
Sale of securities on an exchange or to another person at price $ 10.07 per share. |
04 Jun 2025 |
38,227 |
0
|
-
|
10.1 |
384,946
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
8,400 |
144,303
|
-
|
4.3 |
36,120
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
43,882 |
43,882
|
-
|
4.3 |
188,693
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.15 per share. |
04 Jun 2025 |
43,882 |
0
|
-
|
10.1 |
445,402
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.21 per share. |
04 Jun 2025 |
8,400 |
135,903
|
-
|
10.2 |
85,764
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
43,882 |
43,882
|
-
|
4.3 |
188,693
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.21 per share. |
04 Jun 2025 |
43,882 |
0
|
-
|
10.2 |
448,035
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,400 |
51,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
43,883 |
269,559
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,400 |
43,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
43,882 |
225,677
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
8,400 |
34,800
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jun 2025 |
43,882 |
181,795
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
8,400 |
144,303
|
-
|
4.3 |
36,120
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.10 per share. |
04 Jun 2025 |
8,400 |
135,903
|
-
|
10.1 |
84,840
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
43,883 |
43,883
|
-
|
4.3 |
188,697
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.10 per share. |
04 Jun 2025 |
43,883 |
0
|
-
|
10.1 |
443,218
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
04 Jun 2025 |
8,400 |
144,303
|
-
|
4.3 |
36,120
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 10.15 per share. |
04 Jun 2025 |
8,400 |
135,903
|
-
|
10.2 |
85,260
|
Common Stock |
Tim Van Hauwermeiren
|
Director |
|
13 May 2025 |
22,346 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tim Van Hauwermeiren
|
Director |
|
13 May 2025 |
22,346 |
22,346
|
-
|
4.3 |
96,088
|
Common Stock |
Ansbert Gadicke
|
Former 10% Owner |
Sale of securities on an exchange or to another person at price $ 8.06 per share. |
13 May 2025 |
1,031,931 |
3,452,797
|
-
|
8.1 |
8,317,364
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
77,000 |
135,903
|
-
|
|
0
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
459,000 |
459,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Call
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
24,000 |
161,898
|
-
|
|
0
|
Common Stock |
Matthew Call
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
145,000 |
145,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Gall
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
24,000 |
89,429
|
-
|
|
0
|
Common Stock |
Matthew Gall
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
145,000 |
145,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
15,300 |
46,300
|
-
|
|
0
|
Common Stock |
Yvonne McGrath
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2025 |
91,000 |
91,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Feltquate David
|
Chief Medical Officer |
|
06 Dec 2024 |
47,000 |
47,000
|
-
|
|
0
|
Common Stock |
Matthew Gall
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 7.73 per share. |
19 Nov 2024 |
5,000 |
65,429
|
-
|
7.7 |
38,635
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
08 Aug 2024 |
442,800 |
442,800
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
08 Aug 2024 |
442,800 |
147,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Feltquate
|
Chief Medical Officer |
|
01 Aug 2024 |
350,000 |
350,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ann D. Rhoads
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
David L. Hallal
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tim Van Hauwermeiren
|
Director |
|
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tony W. Ho
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Aaron I. Davis
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert Iannone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jill DeSimone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
David K. Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2024 |
24,200 |
24,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2024 |
590,400 |
590,400
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Call
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2024 |
225,000 |
225,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Gall
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2024 |
163,200 |
163,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2024 |
153,600 |
153,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jill DeSimone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Mar 2024 |
44,766 |
44,766
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Dec 2023 |
30,000 |
58,903
|
-
|
|
0
|
Common Stock |
Call Matthew
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Dec 2023 |
44,000 |
137,898
|
-
|
|
0
|
Common Stock |
David Lee K.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Dec 2023 |
44,766 |
44,766
|
-
|
|
-
|
Stock Option (Right to Buy) |
McGrath Yvonne
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Dec 2023 |
31,000 |
31,000
|
-
|
|
0
|
Common Stock |
Gall Matthew
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Dec 2023 |
41,000 |
60,429
|
-
|
|
0
|
Common Stock |
Ann D. Rhoads
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
22,383 |
22,383
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Hallal
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
22,383 |
22,383
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tim Van Hauwermeiren
|
Director |
|
13 Jun 2023 |
22,383 |
22,383
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert Iannone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
22,383 |
22,383
|
-
|
|
-
|
Stock Option (Right to Buy) |
Derek DiRocco
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
13 Jun 2023 |
22,383 |
22,383
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Call
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.95 per share. |
28 Mar 2023 |
40,226 |
93,898
|
-
|
3.0 |
118,667
|
Common Stock |
Matthew Call
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
28 Mar 2023 |
40,226 |
107,864
|
-
|
|
-
|
Stock Option (right to buy) |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2023 |
346,000 |
346,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Mar 2023 |
254,997 |
91,003
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
09 Mar 2023 |
254,997 |
254,997
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Call
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2023 |
130,000 |
130,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Gall
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2023 |
130,000 |
130,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2023 |
130,000 |
130,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Mar 2023 |
130,000 |
130,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Dec 2022 |
264,375 |
88,125
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Dec 2022 |
264,375 |
264,375
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Apr 2022 |
11,500 |
144,464
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 32.64 per share. |
18 Apr 2022 |
33 |
26,263
|
-
|
32.6 |
1,077
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 31.87 per share. |
18 Apr 2022 |
11,467 |
26,296
|
-
|
31.9 |
365,453
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. |
18 Apr 2022 |
11,500 |
37,763
|
-
|
4.2 |
48,645
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 34.11 per share. |
21 Mar 2022 |
9,908 |
28,970
|
-
|
34.1 |
337,962
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 36.51 per share. |
21 Mar 2022 |
1,548 |
26,263
|
-
|
36.5 |
56,517
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 35.22 per share. |
21 Mar 2022 |
1,159 |
27,811
|
-
|
35.2 |
40,820
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 33.44 per share. |
21 Mar 2022 |
5,822 |
38,878
|
-
|
33.4 |
194,688
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Mar 2022 |
10,000 |
44,700
|
-
|
|
0
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Mar 2022 |
352,500 |
352,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Call
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Mar 2022 |
85,000 |
85,000
|
-
|
|
-
|
Option (right to buy) |
Matthew Gall
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Mar 2022 |
85,000 |
85,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
11 Mar 2022 |
3,500 |
3,500
|
-
|
4.3 |
15,050
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 36.01 per share. |
11 Mar 2022 |
3,500 |
0
|
-
|
36.0 |
126,035
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Mar 2022 |
85,000 |
85,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Mar 2022 |
3,500 |
178,938
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Mar 2022 |
85,000 |
85,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2022 |
10,000 |
85,123
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.24 per share. |
01 Mar 2022 |
10,000 |
10,000
|
-
|
4.2 |
42,400
|
Common Stock |
Yvonne McGrath
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 36.76 per share. |
01 Mar 2022 |
10,000 |
0
|
-
|
36.8 |
367,570
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 35.32 per share. |
23 Feb 2022 |
544 |
34,700
|
-
|
35.3 |
19,214
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 34.30 per share. |
23 Feb 2022 |
13,956 |
35,244
|
-
|
34.3 |
478,691
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
11 Feb 2022 |
3,500 |
3,500
|
-
|
4.3 |
15,050
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Feb 2022 |
3,500 |
182,438
|
-
|
|
-
|
Stock Option (right to buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 36.27 per share. |
11 Feb 2022 |
1,518 |
0
|
-
|
36.3 |
55,058
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 35.52 per share. |
11 Feb 2022 |
1,982 |
1,518
|
-
|
35.5 |
70,401
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 36.21 per share. |
25 Jan 2022 |
4,412 |
49,200
|
-
|
36.2 |
159,759
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 35.45 per share. |
25 Jan 2022 |
10,088 |
53,612
|
-
|
35.5 |
357,620
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 39.25 per share. |
14 Jan 2022 |
2,777 |
723
|
-
|
39.2 |
108,997
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 Jan 2022 |
3,500 |
185,938
|
-
|
|
-
|
Stock Option (Right to Buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 39.58 per share. |
14 Jan 2022 |
723 |
0
|
-
|
39.6 |
28,616
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
14 Jan 2022 |
3,500 |
3,500
|
-
|
4.3 |
15,050
|
Common Stock |
Detlev Biniszkiewicz
|
Director |
Sale of securities on an exchange or to another person at price $ 51.90 per share. |
03 Jan 2022 |
3,500 |
0
|
-
|
51.9 |
181,650
|
Common Stock |
Detlev Biniszkiewicz
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jan 2022 |
3,500 |
13,108
|
-
|
|
-
|
Stock Option (Right to Buy) |
Detlev Biniszkiewicz
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.00 per share. |
03 Jan 2022 |
3,500 |
3,500
|
-
|
19 |
66,500
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 51.90 per share. |
03 Jan 2022 |
7,000 |
0
|
-
|
51.9 |
363,300
|
Common Stock |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Jan 2022 |
7,000 |
189,438
|
-
|
|
-
|
Stock Option (Right to Buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
03 Jan 2022 |
7,000 |
7,000
|
-
|
4.3 |
30,100
|
Common Stock |
Matthew Gall
|
Chief Financial Officer |
Sale of securities on an exchange or to another person at price $ 46.45 per share. |
27 Dec 2021 |
5,000 |
14,429
|
-
|
46.5 |
232,250
|
Common Stock |
David Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
20 Dec 2021 |
20,000 |
20,000
|
-
|
4.3 |
86,000
|
Common Stock |
David Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Dec 2021 |
30,000 |
37,039
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 Dec 2021 |
20,000 |
114,682
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Hallal
|
Director |
Sale of securities on an exchange or to another person at price $ 43.57 per share. |
20 Dec 2021 |
50,000 |
0
|
-
|
43.6 |
2,178,500
|
Common Stock |
David Hallal
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.95 per share. |
20 Dec 2021 |
30,000 |
50,000
|
-
|
3.0 |
88,500
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
106,200 |
37,800
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
776,600 |
776,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
776,600 |
258,824
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
52,700 |
52,700
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
52,700 |
17,544
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
185,000 |
185,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
185,000 |
155,964
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
313,442 |
313,442
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
313,442 |
90,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 45.37 per share. |
02 Dec 2021 |
9,493 |
63,700
|
-
|
45.4 |
430,697
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 44.62 per share. |
02 Dec 2021 |
5,007 |
73,193
|
-
|
44.6 |
223,412
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 44.92 per share. |
02 Dec 2021 |
149 |
78,200
|
-
|
44.9 |
6,693
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 44.31 per share. |
02 Dec 2021 |
1,514 |
78,349
|
-
|
44.3 |
67,085
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
02 Dec 2021 |
1,663 |
79,863
|
-
|
4.3 |
7,151
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 45.06 per share. |
02 Dec 2021 |
5,580 |
78,200
|
-
|
45.1 |
251,435
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 44.15 per share. |
02 Dec 2021 |
13,646 |
83,780
|
-
|
44.2 |
602,471
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
02 Dec 2021 |
19,226 |
97,426
|
-
|
4.3 |
82,672
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 43.94 per share. |
02 Dec 2021 |
9,111 |
78,200
|
-
|
43.9 |
400,337
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.30 per share. |
02 Dec 2021 |
9,111 |
87,311
|
-
|
4.3 |
39,177
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Dec 2021 |
1,663 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Dec 2021 |
19,226 |
61,663
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Dec 2021 |
9,111 |
80,889
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
02 Dec 2021 |
106,200 |
106,200
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 36.08 per share. |
22 Nov 2021 |
14,500 |
78,200
|
-
|
36.1 |
523,160
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
22 Nov 2021 |
16,263 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Michel Detheux
|
Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.45 per share. |
22 Nov 2021 |
16,263 |
92,700
|
-
|
12.4 |
202,474
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.00 per share. |
01 Nov 2021 |
81 |
96,913
|
-
|
28 |
2,268
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.89 per share. |
01 Nov 2021 |
6,085 |
76,437
|
-
|
28.9 |
175,777
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.41 per share. |
01 Nov 2021 |
14,391 |
82,522
|
-
|
28.4 |
408,920
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.00 per share. |
21 Oct 2021 |
196 |
96,994
|
-
|
28 |
5,488
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.00 per share. |
15 Oct 2021 |
201 |
97,190
|
-
|
28 |
5,628
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.01 per share. |
15 Oct 2021 |
1,635 |
97,391
|
-
|
28.0 |
45,796
|
Common Stock |
Matthew Gall
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
11 Oct 2021 |
14,429 |
42,388
|
-
|
|
-
|
Stock Option (right to buy) |
Matthew Gall
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.16 per share. |
11 Oct 2021 |
14,429 |
19,429
|
-
|
6.2 |
88,883
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.16 per share. |
23 Sep 2021 |
5,322 |
100,115
|
-
|
28.2 |
149,862
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.02 per share. |
23 Sep 2021 |
1,089 |
99,026
|
-
|
28.0 |
30,512
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.12 per share. |
27 Aug 2021 |
4,093 |
125,689
|
-
|
28.1 |
115,095
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.01 per share. |
27 Aug 2021 |
2,322 |
129,782
|
-
|
28.0 |
65,039
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.17 per share. |
27 Aug 2021 |
8,248 |
132,104
|
-
|
28.2 |
232,346
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.06 per share. |
23 Aug 2021 |
7,499 |
141,438
|
-
|
28.1 |
210,422
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.00 per share. |
23 Aug 2021 |
861 |
140,352
|
-
|
28.0 |
24,109
|
Common Stock |
Michel Detheux
|
Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.26 per share. |
23 Aug 2021 |
225 |
141,213
|
-
|
28.3 |
6,359
|
Common Stock |
Matthew Call
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.95 per share. |
30 Jul 2021 |
53,672 |
53,672
|
-
|
2.9 |
158,332
|
Common Stock |
Matthew Call
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
30 Jul 2021 |
53,672 |
148,090
|
-
|
|
-
|
Stock Option (right to buy) |
Ann D. Rhoads
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jun 2021 |
16,608 |
16,608
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Hallal
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jun 2021 |
16,608 |
16,608
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tim Van Hauwermeiren
|
Director |
|
17 Jun 2021 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert Iannone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jun 2021 |
4,560 |
4,560
|
-
|
|
-
|
Stock Option (Right to Buy) |
Detlev Biniszkiewicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jun 2021 |
16,608 |
16,608
|
-
|
|
-
|
Stock Option (Right to Buy) |
Derek DiRocco
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jun 2021 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Roden
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jun 2021 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Gall
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 26.09 per share. |
16 Jun 2021 |
5,000 |
5,000
|
-
|
26.1 |
130,447
|
Common Stock |
Michel Detheux
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 29.26 per share. |
14 Jun 2021 |
3,937 |
148,937
|
-
|
29.3 |
115,199
|
Common Stock |
Michel Detheux
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 28.38 per share. |
14 Jun 2021 |
25,063 |
152,874
|
-
|
28.4 |
711,336
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
08 Jun 2021 |
7,927 |
0
|
-
|
20 |
158,540
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Jun 2021 |
7,927 |
95,123
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. |
08 Jun 2021 |
7,927 |
7,927
|
-
|
4.2 |
33,531
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. |
01 Jun 2021 |
7,604 |
7,604
|
-
|
4.2 |
32,165
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2021 |
323 |
103,050
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2021 |
7,604 |
103,373
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 20.00 per share. |
01 Jun 2021 |
323 |
0
|
-
|
20 |
6,460
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. |
01 Jun 2021 |
323 |
323
|
-
|
4.2 |
1,366
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 20.18 per share. |
01 Jun 2021 |
7,604 |
0
|
-
|
20.2 |
153,443
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 21.92 per share. |
24 May 2021 |
7,927 |
0
|
-
|
21.9 |
173,796
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
24 May 2021 |
7,927 |
110,977
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. |
24 May 2021 |
7,927 |
7,927
|
-
|
4.2 |
33,531
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.23 per share. |
17 May 2021 |
7,926 |
7,926
|
-
|
4.2 |
33,527
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 May 2021 |
7,926 |
118,904
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 26.01 per share. |
17 May 2021 |
90 |
0
|
-
|
26.0 |
2,341
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 25.43 per share. |
17 May 2021 |
2,029 |
90
|
-
|
25.4 |
51,602
|
Common Stock |
Yvonne McGrath
|
VP, Research and Development |
Sale of securities on an exchange or to another person at price $ 24.41 per share. |
17 May 2021 |
5,807 |
2,119
|
-
|
24.4 |
141,777
|
Common Stock |
Robert Iannone
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Apr 2021 |
33,217 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
144,000 |
144,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Call
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
72,000 |
72,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Gall
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
72,000 |
72,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Joanne Jenkins Lager
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
122,000 |
122,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Yvonne McGrath
|
VP, Research and Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2021 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Matthew Roden
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Nov 2020 |
33,217 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ann D. Rhoads
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jul 2020 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Hallal
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jul 2020 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Tim Van Hauwermeiren
|
Director |
|
23 Jul 2020 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Detlev Biniszkiewicz
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jul 2020 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Derek DiRocco
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jul 2020 |
16,608 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michel Detheux
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jul 2020 |
1,035,424 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |